4//SEC Filing
Rizvi Qasim 4
Accession 0001179110-21-000197
CIK 0001730430other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:07 PM ET
Size
8.2 KB
Accession
0001179110-21-000197
Insider Transaction Report
Form 4
Rizvi Qasim
Chief Commercial Officer
Transactions
- Tax Payment
Class A Common Share
2020-12-31$17.67/sh−2,161$38,185→ 5,176 total - Exercise/Conversion
Class A Common Share
2020-12-31+7,337→ 7,337 total - Exercise/Conversion
Restricted Share Unit
2020-12-31−7,337→ 0 total→ Class A Common Share (7,337 underlying)
Footnotes (2)
- [F1]Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.
- [F2]The RSU will vest in a single installment on December 31, 2020, subject to the Reporting Person's continuous employment or service to the Issuer or any of its subsidiaries on the vesting date; there is no expiration date for the RSU.
Documents
Issuer
Kiniksa Pharmaceuticals, Ltd.
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001794636
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:07 PM ET
- Size
- 8.2 KB